Clarissa Desjardins logo

Clarissa Desjardins

North America, Quebec, Canada, Montréal

Description

Dr. Desjardins is the Founder and CEO of the Clementia Pharmaceuticals Inc. Previously, Clarissa was CEO at the Center of Excellence in Pers...

Investor Profile

Clarissa Desjardins has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in Canada.
  • Strong thematic focus on Biotechnology, Medical.

Stage Focus

  • Series A (100%)

Country Focus

  • Canada (100%)

Industry Focus

  • Biotechnology
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Clarissa Desjardins frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 1
Amplitude Venture Capital
North America, Quebec, Canada, Montréal
Co-Investments: 1
DC
North America, Illinois, United States, Chicago
Co-Investments: 1
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 1
Investissement Quebec
North America, Quebec, Canada, Quebec
Co-Investments: 1

What are some of recent deals done by Clarissa Desjardins?

Congruence Therapeutics

Montréal, Quebec, Canada

Congruence Therapeutics operates as a biotechnology company.

BiotechnologyMedical
Series AFeb 8, 2022
Amount Raised: $49,581,196